Abstract
There is sound clinical evidence that many benign breast conditions, especially pain, nodularity, and cysts, are likely to have their pathogenesis in hormonal events during reproductive life. Yet the classical theories of persisting hyperestrogenism and luteal progestogen deficiency have not stood up to detailed investigation. Recent work has demonstrated the importance of dynamic hormonal changes and of chronobiological rhythms—daily, menstrual, and seasonal. Recent developments and findings are reviewed to point to the directions in which the basic etiology of these conditions is likely to be discovered.
Résumé
De solides arguments cliniques confirment que bien de symptômes ou maladies bénignes du sein, notamment douleur, nodules, et kystes, trouvent leur explication pathogénétique dans les évènements hormonaux de la patiente fertile. Cependant, les théories classiques de la sécrétion oestrogénique persistante et de la déficience lutéale n'ont pas résisté aux investigations sérieuses. Des travaux récents ont démontré l'importance des variations hormonales dynamiques et des rythmes chronobiologiques—quotidiens, mensuels, et saisonniers. Dans cet article, on fait le point des données et découvertes récentes: l'étiologie de cette pathologie a des chances d'être découverte.
Resumen
Existe evidencia indicativa de que muchas condiciones mamarias benignas, especialmente el dolor, la nodularidad, y los quistes, posiblemente tienen su patogénesis en eventos hormonales que ocurren en el curso de la vida reproductiva. Sin embargo, las teorías clásicas sobre el hiperestrogenismo persistente y la deficiencia de progesterona no han sido motivo de investigación detallada. Trabajos recientes han demostrado la importancia de los cambios dinámicos hormonales y de los ritmos cronobiológicos—diarios, menstruales, y estacionales. Se revisan desarrollos y hallazgos recientes con miras a señalar las direcciones y campos en los cuáles la etiología básica de estas condiciones podría ser dilucidada.
Similar content being viewed by others
References
Robyn, C.: Endocrinological aspects of breast physiology. In Endocrinology of Cystic Breast Disease, A. Angeli, H.L. Bradlow, L. Dogliotti, editors, New York, Raven Press, 1983, pp. 25–34
Withworth, N.S.: Lactation in humans. Psychoneuroendocrinol.13:171, 1988
Underwood, L.E., D'Ercole, A.J.: Insulin and insulin-like growth factors/somatomedins in fetal and neonatal development. Clin. Endocrinol. Metab.13:69, 1984
Oka, T., Yoshimura, M.: Paracrine regulation of mammary gland growth. Clin. Endocrinol. Metab.15:79, 1986
Angeli, A., Dogliotti, L., Faggiuolo, R., Orlandi, F., Bussolati, G.: Fibrocystic Disease of the Breast. A Revisit and New Perspectives, Amsterdam, Excerpta Medica-Elsevier Science Publ., 1984, pp. 1–74
Haagensen, C.D.: The normal physiology of the breast. In Diseases of the Breast, C.D. Haagensen, editor, Philadelphia, W.B. Saunders, 1986, pp. 47–55
Russo, J., Russo, I.H.: Development of the human mammary gland. In The Mammary Gland, M.C. Neville, C.W. Daniel, editors, New York, 1987, pp. 67–93
Hughes, L.E., Mansel, R.E., Webster, D.J.T.: Aberrations of normal development and involution (ANDI): A new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet2:1316, 1987
Bradley, C.J., Kledzik, G.S., Meites, J.: Prolactin and estrogen dependency of rat mammary cancer at early and late stages of development. Cancer Res.36:319, 1976
Welsch, C.W., Nagasawa, H.: Prolactin and murine mammary tumorigenesis: A review. Cancer Res.37:951, 1977
Dogliotti, L., Faggiuolo, R., Muccioli, G., Natoli, V., Sica, G., Di Carlo, F.: Experimental and clinical evidences for a role of prolactin in human breast cancer and the possible usefulness of combining hypoprolatinemic drugs with standard hormonal treatments. In Endocrinology and Malignancy, E.E. Baulieu, S. Jacobelli, W.L. McGuire, editors, Carnforth, The Parthenon Publishing Group, 1986, pp. 168–181
Robyn, C., Meuris, S.: Human prolactin: State of the art. In Abstracts of the 5th International Congress on Prolactin, July 13–16, Kyoto, 1988, p. 6
Di Carlo, R., Muccioli, G., Bellussi, G., Mussa, A.: Presence and characterization of prolactin receptors in human benign breast tumors. Eur. J. Cancer Clin. Oncol.20:635, 1984
Bonneterre, J., Peyrat, J.P., Beuscart, R., Lefebvre, J., Demaille, A.: Prognostic significance of prolactin receptors in human breast cancer. Cancer Res.47:4724, 1987
Shiu, R.P.C., Murphy, L.C., Tsuyuki, D., Myal, Y., Lee-Wing, M., Iwasiow, B.: Biological actions of prolactin in human breast cancer. Recent Progr. Hormone Res.43:277, 1987
Murphy, L.C., Lee-Wing, M., Goldenberg, G.J., Shiu, R.P.C.: Expression of the gene encoding a prolactin-inducible protein by human breast cancersin vivo: Correlation with steroid receptor status. Cancer Res.47:4160, 1987
Peters, F., Schuth, W., Schurich, B., Breckwoldt, M.: Distribution and dynamics of serum prolactin levels in patients with fibrocystic breast disease. Obstet. Gynecol.64:381, 1984
Dogliotti, L., Faggiuolo, R., Ferusso, A., Orlandi, F., Sandrucci, S., Tibo, A., Angeli, A.: Prolactin and thyrotropin response to thyrotropin releasing hormone in premenopausal women with fibrocystic disease of the breast. Hormone Res.21:137, 1985
Waat-Boolsen, S., Eskildsen, P.C., Blaehr, H.: Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast. Cancer56:500, 1985
Parker, D.C., Rossman, L.G., Vanderlaan, E.F.: Sleep-related nychtohemeral and briefly episodic variations in human plasma prolactin concentrations. J. Clin. Endocrinol. Metab.36:1119, 1973
Cole, E.N., Sellwood, R.A., England, P.C., Griffiths, K.: Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Eur. J. Cancer13:597, 1977
Tarquini, B., Gheri, R., Romano, S., Costa, A., Cagnoni, M., Lee, J.K., Halberg, F.: Circadian mesor-hyperprolactinemia in fibrocystic mastopathy. Am. J. Med.66:229, 1979
Tarquini, B., Halberg, F.: Altered circannual prolactin and TSH and circadian melatonin rhythm and risk of developing breast cancer. In Chronobiological Approach to Social Medicine, F. Halberg, L. Reale, B. Tarquini, editors, Rome, Istituto Italiano di Medicina Sociale, 1986, pp. 127–148
Bruning, P.F., Bonfrer, M., De Jong-Bakker, M., Hart, A.A.M., Misdorp, W., Nooyen, W., Kwa, H.G.: Hormone profiles in premenopausal “benign breast disease.” In Abstracts of the 3rd EORTC Breast Cancer Working Conference, Amsterdam, Netherland's Organization for Cancer Research, 1983, p. VII-7
Tarquini, B., Cariddi, A., Granelli, A., Mainardi, G., Sensi, G., Moggi, P., Zennaro, R., Cecchettin, M.: Multiple prolactin dyschronias in benign breast disease (BBD). In Social Diseases and Chronobiology, B. Tarquini, editor, Bologna, Esculapio Publ. Co., 1987, pp. 39–51
Melis, G.B., Guarneri, G., Paoletti, A.M., Petacchi, F.D., Ricci, D., Strigini, F., Selli, M., Ruju, A., Fioretti, P.: Clinical significance of hormonal evaluations in peripheral blood and in breast cyst fluid of women with benign breast disease. In Endocrinology of Cystic Breast Disease, A. Angeli, H.L. Bradlow, L. Dogliotti, editors, New York, Raven Press, 1983, pp. 101–112
Kumar, S., Mansel, R.E., Hughes, L.E., Woodhead, J.S., Edwards, C.A., Scanlon, M.F., Newcombe, R.G.: Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer53:1311, 1984
Aragona, C., Figliolini, M., Tribulato, E., Vetrano, G., Spera, G., Custo, G.M., Pozzi, V.: Studio della prolattina e del progesterone in pazienti con mastopatia fibrocistica sintomatica e asintomatica. Giorn. Ital. Senol.2:1, 1981
Dogliotti, L., Faggiuolo, R., Orlandi, F., Torta, M., Meda, E., Angeli, A.: Prolactin dynamics after acute stimulation with thyrotropin-releasing hormone and domperidone in women with fibrocystic disease of the breast. In Endocrinology of the Breast: Basic and Clinical Aspects, A. Angeli, H.L. Bradlow, L. Dogliotti, editors, New York, The New York Academy of Science, 1986, pp. 589–591
De Brux, J.: Histoire naturelle et diagnostic de quelques lésions mammaires. Rev. Fr. Gynécol.68:365, 1973
Mauvais-Jarvis, P., Sitruk-Ware, R., Kuttenn, F., Sterkers, N.: Luteal phase insufficiency: A common pathophysiological factor in development of benign and malignant breast disease. In Commentaries on Research in Breast Disease, R.D. Bulbrook, D.J. Taylor, editors, New York, Alan R. Liss, 1979, pp. 25–29
England, P.C., Skinner, L.G., Cottrell, K.R., Sellwood, R.A.: Sex hormones in breast disease. Br. J. Surg.62:806, 1975
Mauvais-Jarvis, P., Mutten, F., Mowszowics, I., Sitruk-Ware, R.: Mastopathies benignes: Étude hormonale chez 125 malades. Nouv. Presse Med.6:1115, 1977
Sitruk-Ware, L.R., Sterkers, N., Mowszowics, I., Mauvais-Jarvis, P.: Inadequate corpus luteal function in women with benign breast disease. J. Clin. Endocrinol. Metab.44:771, 1977
Malarkey, W.B., Schroeder, L.L., Stevens, V.C., James, A.G., Lanese, R.R.: Twenty-four hours preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res.37:4655, 1977
Walsh, P., Bulbrook, R.D., Stell, P.M., Wang, D.Y., McDicken, I.W., George, W.D.: Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur. J. Cancer Clin. Oncol.20:1339, 1984
Read, G.F., Bradley, J.A., Wilson, D.W., George, W.D., Griffiths, K.: Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer. Eur. J. Cancer Clin. Oncol.21:9, 1985
Angeli, A., Faggiuolo, R., Berruti, A.: Abnormalities of prolactin secretion in patients with fibrocystic breast disease. In Fibrocystic Breast Disease, L. Dogliotti, R.E. Mansel, editors. Aulendorf, Editio Cantor, 1986, pp. 21–29
Pfeiffer, A., Herz, A.: Endocrine action of opioids. Horm. Metab. Res.16:386, 1984
Pontiroli, A.E., Baio, G., Stella, L., Crescenti, A., Girardi, A.M.: Effects of naloxone on prolactin, luteinizing hormone and cortisol responses to surgical stress in humans. J. Clin. Endocrinol. Metab.55:378, 1982
Santen, R.J., Leszczynski, D., Tilson-Mallet, N., Feil, P.D., Wright, C., Manni, A., Santner, S.J.: Enzymatic control of estrogen production in human breast cancer: Relative significance of aromatase versus sulfatase pathways. In Endocrinology of the Breast: Basic and Clinical Aspects, A. Angeli, H.L. Bradlow, L. Dogliotti, editors, New York, The New York Academy of Sciences, 1986, pp. 126–137.
Santner, S., Leszczynski, D., Wright, C., Manni, A., Feil, P.D., Santen, R.J.: Estrone sulfate: A potential source of estradiol in human breast cancer tissues. Breast Cancer Res. Treat.7:35, 1986
Vermeulen, A., Deslypere, J.P., Paridaens, R.: Steroid dynamics in the normal and carcinomatous mammary gland. J. Steroid Biochem.25:799, 1986
Thijssen, J.H.H., Van Landeghem, A.A.J., Poortman, J.: Uptake and concentration of steroids hormones in mammary tissues. In Endocrinology of the Breast: Basic and Clinical Aspects, A. Angeli, H.L. Bradlow, L. Dogliotti, editors, New York, The New York Academy of Sciences, 1986, pp. 106–116.
Dickson, R.B., Lippman, M.E.: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev.8:29, 1987
Azzopardi, J.G.: Problems in Breast Pathology, Philadelphia, W.B. Saunders, 1979
Haagensen, C.D., Bodian, C., Haagensen, Jr., D.E.: Breast Carcinoma. Risk and Detection, Philadelphia, W.B. Saunders, 1981
Bradlow, H.L., Rosenfeld, R.S., Kream, J., Fleisher, M., O'Connor, J., Schwartz, M.K.: Steroid hormone accumulation in human breast cyst fluid. Cancer Res.41:105, 1981
Frairia, P., Agrimonti, F., Fazzari, A.M., Barbadoro, E., Boccuzzi, G., Angeli, A.: Evidence for a transcortin-like component in human breast cyst fluid. Clin. Chim. Acta131:15, 1983
Rosner, W., Saeed Khan, M., Breed, C.N., Fleisher, M., Bradlow, H.L.: Plasma steroid-binding proteins in the cysts of gross cystic disease of the breast. J. Clin. Endocrinol. Metab.61:200, 1985
Angeli, A., Dogliotti, L., Agrimonti, F., Faggiuolo, R., Cavallo, R., Tibo, A.: Thyroid hormone levels in human breast cyst fluid. Acta Endocrinol.107:230, 1984
Fleisher, M., Robbins, G.F., Breed, C.N., Fracchia, A.A., Urban, J.A., Schwartz, M.K.: The biochemistry of breast cyst fluid. Memorial Sloan Kettering Cancer Center Clin. Bull.3:94, 1973
Miller, W.R., Dixon, J.M., Scott, W.N., Forrest, A.P.M.: Classification of human breast cysts according to electrolyte and androgen conjugate composition. Clin. Oncol.9:227, 1983
Dogliotti, L., Orlandi, F., Torta, M., Buzzi, G., Naldoni, C., Mazzotti, A., Angeli, A.: Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. Eur. J. Cancer Clin. Oncol.22:1307, 1986
Dixon, J.M., Miller, W.R., Scott, W.N., Forrest, A.P.M.: The morphological basis of human breast cyst populations. Br. J. Surg.70:604, 1983
Beccati, D., Grilli, N., Schincaglia, P., Naldoni, C., Tavolazzi, L., Ranaldi, R., Dogliotti, L., Torta, M., Angeli, A.: Apocrine cells in breast cyst fluid and their relationship to cyst type: A morphometric study. Eur. J. Cancer Clin. Oncol.24:597, 1988
Hawkins, R.A., Thomson, M.L., Killen, E.: Oestrone sulphate, adipose tissue, and breast cancer. Breast Cancer Res. Treat.6:75, 1985
Miller, W.R., Humeniuk, V., Kelly, R.W.: Dehydroepiandrosterone sulphate in breast secretions. J. Steroid Biochem.137:145, 1980
Boccuzzi, G., Brignardello, E., Massobrio, M., Bonino, L.: Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. Eur. J. Cancer Clin. Oncol.23:1099, 1987
Rose, D.P., Berke, B., Cohen, L.A., Lahti, H.: A Comparison of serum and breast duct fluid immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic disease. Cancer60:2761, 1987
Tanaka, T., Shiu, R.P.C., Gout, P.W., Beer, C.T., Noble, R.L., Friesen, H.G.: A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab.51:1058, 1980
Author information
Authors and Affiliations
Additional information
This work has been partially supported by the National Research Council (CNR), Rome, Italy, special project “Oncology” contract no. 86.00291.44.
Rights and permissions
About this article
Cite this article
Dogliotti, L., Orlandi, F. & Angeli, A. The endocrine basis of benign breast disorders. World J. Surg. 13, 674–679 (1989). https://doi.org/10.1007/BF01658413
Issue Date:
DOI: https://doi.org/10.1007/BF01658413